Loading...

Table of Content

    20 December 2023, Volume 18 Issue 12
    Chinese Studies Changed the National Clinical Guideline for Stroke for the United Kingdom and Ireland
    XIONG Yunyun, WANG Yongjun
    2023, 18(12):  1337-1342.  DOI: 10.3969/j.issn.1673-5765.2023.12.001
    Asbtract ( )   PDF (4523KB) ( )  
    References | Related Articles | Metrics
    In 2023, the 2016 edition of the national clinical guideline for stroke for the United Kingdom and Ireland were updated 7 years after publication. Based on new research progress and the development of clinical techniques for diagnosis and treatment, this update version provides the latest diagnostic and treatment recommendations for clinical practice. It should be noted that, lots of evidence of the new edition came from Chinese clinical trials. Interpreting this guideline will help Chinese clinical doctors better understand international stroke diagnosis and treatment, enhance evidence-based awareness, and assist in the design and implementation of future international multicenter clinical trials. 
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) 
    XIONG Yunyun
    2023, 18(12):  1343-1343. 
    Asbtract ( )   PDF (553KB) ( )  
    Related Articles | Metrics
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Organisation of Stroke Services
    WANG Wenjie, MAO Jiawen, HOU Yeye, YANG Xin, LI Zixiao
    2023, 18(12):  1344-1351.  DOI: 10.3969/j.issn.1673-5765.2023.12.002
    Asbtract ( )   PDF (7146KB) ( )  
    References | Related Articles | Metrics
    Stroke is a major fatal and disabling disease, bringing heavy burden to individuals, families, and society, which has become a serious public health problem and attracted great attention. To a certain extent, Organisation of stroke services could improve the medical quality of stroke service institutions, enhance the coherence, systematicity, and scientificity of stroke diagnosis, treatment, and rehabilitation, reduce the mortality and disability of stroke, and improve the clinical prognosis and living ability of stroke patients. The National Clinical Guideline for Stroke for the United Kingdom and Ireland (2023 edition) has updated the part of Organisation of stroke services. The paper will explain the update points of this part. 
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Transient Ischemic Attack and Minor Stroke
    MA Ying, LU Zhengzhao, WANG Yongjun
    2023, 18(12):  1352-1356.  DOI: 10.3969/j.issn.1673-5765.2023.12.003
    Asbtract ( )   PDF (4474KB) ( )  
    References | Related Articles | Metrics
    TIA is a transient neurological impairment caused by local cerebral or retinal ischemia, with symptoms lasting less than 24 hours. Minor stroke is usually measured by NIHSS score≤5 or NIHSS score≤3. The 2023 edition of the National Clinical Guideline for Stroke for the United Kingdom and Ireland provided detailed recommendations for the diagnosis, treatment, prevention and management of TIA and minor stroke. This paper provides an interpretation of these recommendations and highlights the updates compared with the 2016 edition of the National Clinical Guideline for Stroke for the United Kingdom and Ireland. 
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Ischemic Stroke
    HAO Manjun, CAO Zhixin, LI Guangshuo, XIONG Yunyun
    2023, 18(12):  1357-1364.  DOI: 10.3969/j.issn.1673-5765.2023.12.004
    Asbtract ( )   PDF (6864KB) ( )  
    References | Related Articles | Metrics
    The treatment of ischemic stroke in acute phase has always been a highly discussed topic. In the seven years since the publication of the 2016 edition of the national clinical guideline for stroke for the United Kingdom and Ireland, there have been significant developments in reperfusion therapy for acute ischemic stroke patients. The 2023 edition of the guidelines updated some recommendations on the acute phase treatment of ischemic stroke based on the 2016 edition. This paper will provide an interpretation of the key update points in the 2023 edition and compare them with the 2019 American Heart Association (AHA) /American Stroke Association (ASA) guidelines for the early management of patients with acute ischemic stroke, and The Chinese Clinical Management Guidelines for Cerebrovascular Diseases (2nd Edition) published in 2023. 
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Hemorrhagic Stroke
    LI Guangshuo, ZHAO Xingquan
    2023, 18(12):  1365-1369.  DOI: 10.3969/j.issn.1673-5765.2023.12.005
    Asbtract ( )   PDF (4050KB) ( )  
    References | Related Articles | Metrics
    Hemorrhagic stroke mainly includes intracerebral hemorrhage and subarachnoid haemorrhage. Although the incidence of hemorrhagic stroke is lower than that of ischemic stroke, the onset is more rapid, the symptoms are more severe, and the prognosis is worse. More importantly, few medical interventions proved efficacy for hemorrhagic stroke, especially intracerebral hemorrhage. Therefore, the updates of hemorrhagic stroke guidelines have drawn much attention. This paper will interpret the updated points of hemorrhagic stroke of the 2023 edition of the national clinical guideline for stroke for the United Kingdom and Ireland.
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Rehabilitation and Recovery
    GUO Shuanghui, ZHANG Yumei
    2023, 18(12):  1370-1382.  DOI: 10.3969/j.issn.1673-5765.2023.12.006
    Asbtract ( )   PDF (10268KB) ( )  
    References | Related Articles | Metrics
    Stroke is one of the major diseases worldwide leading to lifelong disability, and providing effective rehabilitation for stroke patients is important to reduce long-term disability, promote functional independence, and reduce the healthcare burden. The national clinical guideline for stroke for the United Kingdom and Ireland (Edition 2023) developed clinical practice rules of stroke rehabilitation with good operability from six parts: principles of rehabilitation, activity and participation, motor recovery and physical effects of stroke, psychological effects of stroke, communication and language and sensory effects of stroke. This paper will explain the key points of the stroke rehabilitation and recovery.
    Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Long-Term Management and Secondary Prevention 
    WU Na, WANG Liyuan, LI Guangshuo, XIONG Yunyun
    2023, 18(12):  1383-1390.  DOI: 10.3969/j.issn.1673-5765.2023.12.007
    Asbtract ( )   PDF (7129KB) ( )  
    References | Related Articles | Metrics
    The recurrence rate of stroke and TIA is high, and recurrent stroke is characterized by high disability rate and high mortality. Timely, scientific and standardized early, secondary prevention can significantly reduce the risk of recurrent events. The national clinical guideline for stroke for the United Kingdom and Ireland (2023 edition) has updated recommendations on the management of risk factors such as blood pressure, lipid metabolic disorder, antiplatelet therapy, anticoagulant therapy, increased physical activity and secondary prevention measures after stroke or TIA.
    Efficacy and Safety Study of Dual Antiplatelet Versus Alteplase in the Treatment of Acute Mild Non-Disabling Ischemic Stroke
    LI Zhenhua, ZHANG Jiangang, XIE Weizheng, WANG Yu, LUO Xue, LIU Conghui, SUN Ke, YANG Qingcheng, GUO Yanping
    2023, 18(12):  1391-1396.  DOI: 10.3969/j.issn.1673-5765.2023.12.008
    Asbtract ( )   PDF (4698KB) ( )  
    References | Related Articles | Metrics
    Objective  To compare the short-term clinical efficacy and safety of dual antiplatelet and alteplase intravenous thrombolysis in the treatment of acute mild non-disabling ischemic stroke.
    Methods  Patients with mild non-disabling ischemic stroke (NIHSS score≤5, each item score≤1 and consciousness score 0) within 4.5 h of onset were randomly divided into thrombolysis group and dual antiplatelet group. Patients in thrombolysis group were treated with alteplase (0.9 mg/kg) intravenous thrombolysis, and patients in dual antiplatelet group were treated with aspirin enteric-coated tablets combined with clopidogrel hydrogen sulfate tablets. The NIHSS scores of the patients at 7 and 14 days after treatment were evaluated, and the early neurological deterioration and bleeding events within 14 days were recorded. 
    Results  A total of 131 patients were enrolled in the group, including 67 patients in thrombolysis group and 64 patients in dual antiplatelet group. There was no significant difference in NIHSS score between dual antiplatelet group and thrombolysis group on the 7th day (P=0.677) and 14th day (P=0.842) after treatment. The incidence of bleeding events within 14 days in the dual antiplatelet group tended to be lower than that in the thrombolysis group, but the difference was not statistically significant (1.6% vs. 7.5%, P=0.106). The incidence of early neurological deterioration in the dual antiplatelet group was also lower than that in the thrombolysis group, and the difference was not statistically significant (6.3% vs. 13.4%, P=0.169). 
    Conclusions  Ultra-early intravenous thrombolysis with alteplase does not bring significant short-term benefits compared with dual antiplatelet therapy in the treatment of mild non-disabling ischemic stroke, but it does not significantly increase the risk of bleeding. 
    Development and Validation of a Predictive Model for In-Hospital Recurrence Risk in Ischemic Stroke Patients
    CHEN Siding, JIANG Yingyu, WANG Chunjuan, YANG Xin, LI Zixiao, JIANG Yong, WANG Yongjun, GU Hongqiu
    2023, 18(12):  1397-1404.  DOI: 10.3969/j.issn.1673-5765.2023.12.009
    Asbtract ( )   PDF (6708KB) ( )  
    References | Related Articles | Metrics
    Objective  Develop a predictive model for in-hospital recurrence risk of ischemic stroke patients based on machine learning algorithms and externally validate it to provide insights for related research.
    Methods  The development cohort was the China Stroke Center Alliance (CSCA) research cohort, and ischemic stroke patients in this cohort were randomly divided into training and internal validation sets in an 8∶2 ratio. The validation cohort was the Third China National Stroke Registry (CNSR-Ⅲ) research cohort. A list of candidate predictive factors was determined based on guidelines, literature, and data, followed by selection using least absolute shrinkage and selection operator (LASSO) regression. A predictive model for the in-hospital recurrence risk of ischemic stroke patients was developed using logistic regression and machine learning algorithms[random forest model, eXtreme gradient boosting (XGBoost) model, light gradient boosting machine (LightGBM) model]. Model evaluation primarily focused on discrimination (C-statistic) and calibration (Brier score). 
    Results  The CSCA research cohort included 1 587 779 cases of ischemic stroke patients, with 99 085 cases of in-hospital recurrence (6.2%). The CNSR-Ⅲ research cohort included 14 146 cases of ischemic stroke patients, with 623 cases of in-hospital recurrence (4.4%). LASSO feature selection revealed that age, gender, stroke history, hypertension, diabetes, lipid metabolism disorders, atrial fibrillation, heart failure, coronary artery heart disease, peripheral vascular disease, LDL-C, fasting blood glucose, serum creatinine and in-hospital anticoagulation therapy were important predictive factors for predicting in-hospital recurrence of ischemic stroke patients. In internal validation, the discrimination of each model was around 0.75, with XGBoost model slightly outperforming other models (AUC 0.765, 95%CI 0.759-0.770), and the Brier scores for all models were around 0.05. In external validation, the predictive performance of all models was relatively low (AUC<0.60), with Brier scores for all models less than 0.08. 
    Conclusions  In the limited context of the number and dimensions of predictive factors, the efficacy of logistic models and machine learning algorithms in predicting the recurrence risk of stroke was relatively low. Future exploration should involve more investigation into predictive factors and algorithm models.
    Relationship between Obesity and Pressure Ratio in Symptomatic Intracranial Atherosclerosis 
    WANG Anqi, WANG Anxin, ZHANG Yijun, JIANG Yong, ZHANG Yaqing, LIU Li, FU Shengqi, QIN Haiqiang, LIU Gaifen
    2023, 18(12):  1405-1412.  DOI: 10.3969/j.issn.1673-5765.2023.12.010
    Asbtract ( )   PDF (7006KB) ( )  
    References | Related Articles | Metrics
    Objective  To investigate the association between obesity and reduced translesional pressure ratio (PR) in patients with symptomatic intracranial atherosclerosis stenosis (sICAS).
    Methods  Data from this study were obtained from the Chinese National Stroke Registry Ⅲ (CNSR-Ⅲ). sICAS patients with HR-MRI data in the database were included. Three-dimensional meshes were created based on TOF-MRA, and pressure values were obtained by modeling with a finite element method. A PR of≤0.76 between distal and proximal pressure of the stenosis indicated diminished residual blood flow after stenosis. Patients were divided into low or normal weight group, overweight group and obese group according to the BMI. The association between obesity and PR reduction was analyzed by logistic regression, the confounding factors that may affect PR value such as age, sex, history of smoking, history of heavy drinking, history of hypertension, history of diabetes, dyslipidemia, and degree of stenosis were adjusted. 
    Results  A total of 438 patients [median age 64 (57-71) years, 148 cases (33.79%) were female] were included in the analysis. The median PR of the low or normal weight group, the overweight group and the obese group were 0.90 (0.78-0.96), 0.89 (0.73-0.96) and 0.82 (0.52-0.94), respectively, and the difference between the three groups was statistically significant (P=0.044). Multifactorial logistic regression analysis showed that after adjusting for age, sex, history of smoking, history of heavy drinking, history of hypertension, history of diabetes, dyslipidemia and degree of stenosis, obesity was the risk factor for reduced PR in sICAS patients (OR 2.551, 95%CI 1.328-4.902, P=0.005). In addition, in subgroup analysis by age, adjusted for sex, smoking history, heavy drinking history, hypertension history, diabetes history, dyslipidemia, and degrees of stenosis, obesity was the risk factor for reduced PR in patients ≥65 years of age (OR 2.913, 95%CI 1.118-7.590, P=0.029). In subgroup analysis by gender, in female patients, adjusted for age, history of hypertension, history of diabetes, dyslipidemia and degrees of stenosis, obesity was still the risk factor for reduced PR in sICAS patients (OR 3.673, 95%CI 1.174-11.493, P=0.002). 
    Conclusions  Obesity may be a risk factor for reduced PR in sICAS patients. Whether PR can be improved and cerebral perfusion increased by weight loss needs further study. 
    Value of Serum 3-Nitrotyrosine, Serpin Protease Inhibitors B1 Levels in Predicting Prognosis of Elderly Patients with Acute Ischemic Stroke after Intravenous Thrombolysis 
    WANG Le, SHI Qiang, DONG Zhiyan
    2023, 18(12):  1413-1417.  DOI: 10.3969/j.issn.1673-5765.2023.12.011
    Asbtract ( )   PDF (4238KB) ( )  
    References | Related Articles | Metrics
    Objective  To explore the value of serum 3-nitrotyrosine (3-NT) and serpin protease inhibitors B1 (SerpinB1) levels in predicting prognosis of elderly patients with acute ischemic stroke after intravenous thrombolysis.
    Methods  Elderly (≥65 years old) patients with acute ischemic stroke treated in the Department of Neurology, Yan'an University Affiliated Hospital from January 2019 to January 2021 were prospectively and continuously included. According to 90-day mRS score, patients were divided into good prognosis group (0-2 points) and poor prognosis group (>2 points). Serum 3-NT and SerpinB1 levels were collected at baseline and before thrombolysis. Multivariate logistic regression was used to analyze the risk factors of poor prognosis.
    Results   A total of 80 elderly patients with acute ischemic stroke who received intravenous thrombolytic therapy were included, including 45 patients in the good prognosis group and 35 patients in the poor prognosis group. The SerpinB1 level in the poor prognosis group was higher than that in the good prognosis group [(75.24±8.54) ng/mL vs. (57.32±5.68) ng/mL, P<0.001], and the 3-NT expression the in poor prognosis group was also higher than good prognosis group [(75.67±11.22) ng/mL vs. (61.68±11.54) ng/mL, P<0.001]. ROC curve showed that when the 3-NT cutoff value at 70.23 ng/mL, the sensitivity and specificity of predict value of prognosis for acute ischemic stroke in the elderly were 72.54% and 73.28%. When the cut-off value of SerpinB1 was 68.17 ng/mL, the sensitivity of predict value of prognosis for acute ischemic stroke in the elderly was 66.55% and the specificity was 78.64%. Multivariate regression analysis showed that the high NIHSS score (OR 6.404, 95%CI 3.993-10.271, P<0.001), high SerpinB1 expression (OR 26.154, 95%CI 11.460-59.690, P<0.001) and high 3-NT expression (OR 12.769, 95%CI 4.635-35.174, P<0.001) were the risk factors for poor prognosis of intravenous thrombolysis in elderly patients with acute ischemic stroke. 
    Conclusions  Baseline serum 3-NT and SerpinB1 have certain value in the prognosis assessment of elderly patients with acute ischemic stroke after intravenous thrombolysis.
    Meta-analysis of the Efficacy of Ginkgo Biloba Extract Injection in Posterior Circulation Ischemia Vertigo
    PING Man, PAN Peiyan, MI Donghua
    2023, 18(12):  1418-1428.  DOI: 10.3969/j.issn.1673-5765.2023.12.012
    Asbtract ( )   PDF (8251KB) ( )  
    References | Related Articles | Metrics
    Objective  To evaluate the clinical efficacy and safety of ginkgo biloba extract injection in posterior circulation ischemia vertigo (PCIV).
    Methods  Primariy studies were systematically searched from the databases of CNKI, WanFang, VIP, PubMed, Embase and Cochrane Library published before July 2022. Randomed controlled trials (RCTs) reporting efficacy of ginkgo biloba extract injection in treatment of PCIV were included, the experimental group was ginkgo biloba extract injection, and the control group was anti-vertigo drugs. The Cochrane Collaboration bias risk assessment tool was used to measure the methodological quality of included studies. The meta-analysis was performed using the program RevMan 5.4.3 to analysis the difference of clinical total effective rate, cerebral blood flow velocity after treatment and blood viscosity index between the experimental group and control group. 
    Results  A total of 16 RCTs were finally included, involving 1545 patients (785 patients in experimental group and 760 patients in control group. Meta-analysis showed that the clinical total effective rate (OR 4.03, 95%CI 2.90-5.61, P<0.001), the left vertebral artery flow velocity[weighted mean difference (WMD) 4.81, 95%CI 2.91-6.71, P<0.001], the right vertebral artery flow velocity (WMD 4.70, 95%CI 2.80-6.60, P<0.001) and the basilar artery flow velocity (WMD 5.05, 95%CI 3.07-7.03, P<0.001) in the experimental group were all better than those in the control group. 
    Conclusions  Ginkgo biloba extract injection could improve the clinical efficacy of PCIV, and could improve the blood flow velocity of vertebrobasilar artery. 
    Chinese Expert Consensus 2023 on Endovascular Treatment for Acute Large Vessel Occlusion with Mild Stroke
    Chinese Interventional Neuroradiology Society of Chinese Stroke Association
    2023, 18(12):  1429-1449.  DOI: 10.3969/j.issn.1673-5765.2023.12.013
    Asbtract ( )   PDF (17993KB) ( )  
    References | Related Articles | Metrics
    Chinese Expert Consensus 2023 on Endovascular Treatment for Acute Large Vessel Occlusion with Mild Stroke is a summary and analysis of the new progress and new evidence obtained from the recent studies on endovascular treatment for acute large vessel occlusion with mild stroke by the experts organized by the Chinese Interventional Neuroradiology Society of Chinese Stroke Association. This expert consensus covers the definition of mild stroke, and intravenous thrombolysis and endovascular treatment for acute large vessel occlusion that begins with mild stroke. The aim is to provide guidance for professionals and social workers engaged in stroke prevention and treatment, especially the endovascular treatment, care and rehabilitation of acute ischemic stroke, as well as relevant governmental agencies, healthcare administrators, pharmaceutical companies, healthcare demand parties, and other stakeholders. 
    Quality Control Indicators in Neurocritical Care
    The Neurocritical Care Working Group of National Center for Healthcare Quality Management in Neurological Diseases
    2023, 18(12):  1450-1455.  DOI: 10.3969/j.issn.1673-5765.2023.12.014
    Asbtract ( )   PDF (4601KB) ( )  
    References | Related Articles | Metrics
    Neurocritical care is an interdisciplinary discipline at the intersection of clinical neuroscience and critical care medicine that treats patients with neurological diseases and present or potential organ dysfunction. In China, neurocritical care was established late and faces issues like uneven distribution of resources, practitioners with diverse backgrounds, and large differences in treatment concept and the level of diagnosis and treatment. According to the current situation of neurological care in China, based on the existing evidence-based data, drawing on domestic and international quality indicators, the Neurocritical Care Working Group of National Center for Healthcare Quality Management in Neurological Diseases organized experts in neurocritical care to develop the "Quality Control Indicators in Neurocritical Care" using a modified Delphi method. This indicator set includes a total of 23 indicators, categorized as process indicators, readmission indicators, and key disease indicators. The formulation of medical quality control indicator of neurocritical care will provide the first set of data indicator system that can be monitored for the improvement of neurocritical care quality in China. Continuously monitoring of this indicator system will enable longitudinal and cross-sectional comparisons. Targeted training programs based on these indicators will improve the understanding of medical staff on neurological care, standardize clinical practices, and improve the medical quality of neurocritical care.  
    Neurocritical Care Quality Control 2018—2023: From Resource Investigation to Quality Control Indicators
    ZHANG Linlin, ZHOU Jianxin
    2023, 18(12):  1456-1459.  DOI: 10.3969/j.issn.1673-5765.2023.12.015
    Asbtract ( )   PDF (3109KB) ( )  
    References | Related Articles | Metrics
    The neurocritical care working group of the National Center for Healthcare Quality Management in Neurological Diseases was established in 2018. The working group conducted national surveys of sentinel hospitals and investigations of neurocritical care resources, discovering issues in China's neurocritical care such as uneven distribution of medical resources and lack of specialized personnel. Based on the survey results, the working group developed a system of quality control indicators for neurocritical care using the Delphi method, covering process indicators, readmission indicators, and key disease-related indicators. In addition, the neurocritical care working group also formulated the core knowledge and competencies consensus in neurocritical care and the consensus on sedation and analgesia for neurocritical care patients, and carried out a series of training programs such as the Neuro-Shield Action to promote continuous improvement in the quality of neurocritical care. In the future, the working group will continue to carry out activities such as quality control programs, training and assessment, and regularly monitor the implementation of quality control indicators to promote continuous improvement of medical quality. This paper summarizes the work of the neurocritical care working group in promoting improvements in the quality of neurocritical care in China. 
    Construction and Application of Individualized Visual Health Education Program
    WU Meiru, CHEN Yitong, MIAO Yajie, LIU Xingchi, GONG Xiping
    2023, 18(12):  1460-1464.  DOI: 10.3969/j.issn.1673-5765.2023.12.016
    Asbtract ( )   PDF (4662KB) ( )  
    References | Related Articles | Metrics
    Objective  To construct individualized visual health education program and explore its application effect in patients with ischemic stroke. 
    Methods  Patients with ischemic stroke admitted to Ward 2 of Department of Vascular Neurology, Beijing Tiantan Hospital, Capital Medical University from August 2020 to December 2022 were prospectively included as subjects by convenience sampling method. The personalized visual health education form based on hospital information system was adopted to analyze the frequency of use of health education videos, compliance of patients taking antihypertensive, hypoglycemic, antiplatelet aggregation, or lipid-lowering drugs, patient satisfaction and nurse satisfaction. 
    Results  A total of 1569 patients were included, and no patient died during the intervention period. Since the implementation of the individualized visual health education program in August 2020, the dimension of health education videos watched most was diet rehabilitation education, the average viewing frequency was (2.30±1.15) times/day, and the difference in the scores of 8-item Morisky  edication adherence scale before and after intervention was statistically significant [(6.30±1.30) points vs. (4.80±1.17) points, t=39.96, P<0.0001]. The very satisfaction rate of patients was 95.8% (1503/1569), and that of nurses was 94.1% (16/17). 
    Conclusions  Individualized visual health education program is beneficial to improve the medication compliance of patients, and can improve the satisfaction of patients and nurses. 
    CSA Declaration of Next-generation Reperfusion Therapy for Ischemic Stroke
    Chinese Stroke Association
    2023, 18(12):  1465-1466.  DOI: 10.3969/j.issn.1673-5765.2023.12.017
    Asbtract ( )   PDF (1539KB) ( )  
    Related Articles | Metrics